Your browser doesn't support javascript.
loading
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis.
Puzanov, Igor; Subramanian, Poornima; Yatsynovich, Yan V; Jacobs, David M; Chilbert, Maya R; Sharma, Umesh C; Ito, Fumito; Feuerstein, Steven G; Stefanovic, Filip; Switzer, Benjamin; Hicar, Mark D; Curtis, Anne B; Spangenthal, Edward J; Dy, Grace K; Ernstoff, Marc S; Vachhani, Pankit; Page, Brian J; Agrawal, Nikhil; Khunger, Arjun; Kapoor, Ankita; Hattoum, Alexander; Schentag, Jerome J.
Afiliação
  • Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA igor.puzanov@roswellpark.org.
  • Subramanian P; CPL Associates, Buffalo, New York, USA.
  • Yatsynovich YV; Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
  • Jacobs DM; CPL Associates, Buffalo, New York, USA.
  • Chilbert MR; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.
  • Sharma UC; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.
  • Ito F; Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
  • Feuerstein SG; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Stefanovic F; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Switzer B; Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA.
  • Hicar MD; CPL Associates, Buffalo, New York, USA.
  • Curtis AB; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.
  • Spangenthal EJ; CPL Associates, Buffalo, New York, USA.
  • Dy GK; Department of Biomedical Engineering, University at Buffalo School of Engineering and Applied Sciences, Buffalo, New York, USA.
  • Ernstoff MS; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Vachhani P; Department of Pediatrics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
  • Page BJ; Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
  • Agrawal N; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Khunger A; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Kapoor A; Division of Cancer Treatment and Diagnosis/Developmental Therapeutics Program, National Cancer Institute, Rockville, Maryland, USA.
  • Hattoum A; Department of Medicine, Division of Hematology and Oncology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Schentag JJ; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
J Immunother Cancer ; 9(6)2021 06.
Article em En | MEDLINE | ID: mdl-34162715

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Miocardite Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Miocardite Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos